Literature DB >> 12393414

Megakaryocyte polyploidization is associated with a functional gene amplification.

Hana Raslova1, Lydia Roy, Claire Vourc'h, Jean Pierre Le Couedic, Olivier Brison, Didier Metivier, Jean Feunteun, Guido Kroemer, Najet Debili, William Vainchenker.   

Abstract

It is believed that polyploidy induces an orchestrated increase in gene expression. To know whether all alleles remain functional during megakaryocyte polyploidization, we used a well-established fluorescence in situ hybridization technique which allows one to simultaneously detect pre-mRNAs and assess ploidy level in a single cell. All alleles of GPIIb, GPIIIa, VWF, beta-actin, hsp70, c-mpl, Fli-1, and FOG-1 genes are transcriptionally active in megakaryocytes from 4N to 32N. All X chromosomes in male cells are transcriptionally active but only half of them are transcriptionally active in female megakaryocytes, as revealed by the transcriptional activity of the GATA-1 gene. Nuclear untranslated XIST RNA accumulates on the inactivated X chromosomes, indicating that they are subjected to a normal inactivation process. Altogether, our results demonstrate that megakaryocyte polyploidization results in a functional gene amplification whose likely function is an increase in protein synthesis parallel with cell enlargement.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393414     DOI: 10.1182/blood-2002-05-1553

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte.

Authors:  Richard N Carter; Gwen Tolhurst; Gemma Walmsley; Matthieu Vizuete-Forster; Nigel Miller; Martyn P Mahaut-Smith
Journal:  J Physiol       Date:  2006-07-20       Impact factor: 5.182

2.  Internuclear chromosome distribution of dysplastic megakaryocytes in myelodysplastic syndromes is dependent on the level of ploidy.

Authors:  Claudia Münch; Annette M May; Dieter Hauschke; Jasmine Roth; Silke Lassmann; Martin Werner
Journal:  Chromosoma       Date:  2011-02-01       Impact factor: 4.316

3.  Dynamic transcription factor activity profiles reveal key regulatory interactions during megakaryocytic and erythroid differentiation.

Authors:  Mark T Duncan; Seungjin Shin; Jia J Wu; Zachary Mays; Stanley Weng; Neda Bagheri; William M Miller; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2014-07-14       Impact factor: 4.530

Review 4.  Somatic polyploidy promotes cell function under stress and energy depletion: evidence from tissue-specific mammal transcriptome.

Authors:  Olga V Anatskaya; Alexander E Vinogradov
Journal:  Funct Integr Genomics       Date:  2010-07-13       Impact factor: 3.410

Review 5.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

6.  Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors.

Authors:  Danuta Jarocha; Karen K Vo; Randolph B Lyde; Vincent Hayes; Rodney M Camire; Mortimer Poncz
Journal:  Blood Adv       Date:  2018-03-27

7.  Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production.

Authors:  Camelia Iancu-Rubin; David Gajzer; Joseph Tripodi; Vesna Najfeld; Ronald E Gordon; Ronald Hoffman; George F Atweh
Journal:  Blood       Date:  2011-03-01       Impact factor: 22.113

Review 8.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

9.  Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia.

Authors:  Diane S Krause; John D Crispino
Journal:  Clin Cancer Res       Date:  2013-08-20       Impact factor: 12.531

10.  FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia.

Authors:  Hana Raslova; Emiko Komura; Jean Pierre Le Couédic; Frederic Larbret; Najet Debili; Jean Feunteun; Olivier Danos; Olivier Albagli; William Vainchenker; Rémi Favier
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.